The American Society of Clinical Oncology (ASCO) recommendations for Treatment of Multiple Myeloma is now to the public for comment.
ASCO is collecting feedback through Tuesday, May 27, 2025. Individuals interested submit feedback on the ASCO website.
ASCO guidelines are typically available for public comment for two to three weeks. Individuals must sign a confidentiality agreement before they can view the recommended guideline or guideline update.
Copyright © 2025 Guideline Central, all rights reserved.